Recruiting
Phase 2

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05429320

Conditions

Non-small Cell Lung Cancer

Metastatic Non Small Cell Lung Cancer

Nsclc

NSCLC Stage IV

Minimal Residual Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Local ablative therapy

Blood collection to assess for ctDNA

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information